A rebound is here, but can it last? Here's what the experts think. The post After losing half their value, can CSL shares ...

Learn More There was a time when CSL Ltd (ASX: CSL) could almost do no wrong in the eyes of investors. But that now feels ...

CSL shares have plunged sharply over the past year, with analysts questioning earnings outlook, valuation, and acquisition performance.

Here is how Carlisle (CSL) and Sumitomo Corp. (SSUMY) have performed compared to their sector so far this year.

Casual pub with a menu that riffs on English classics.

After an antitrust review knocked 2021’s biggest biopharma buyout off course in May, CSL’s $11.7 billion deal for Swiss iron deficiency specialist Vifor Pharma appears to be back on track. Tuesday, ...

Earlier this year, BMW debuted the M4 CS, a car designed to sit between the Competition Package and the ultra-hardcore M4 GTS. Of course, bringing back the CS designation, which stands for Coupe Sport ...

The S&P/ASX 200 Healthcare index has jumped 17% since early June. Is the sector onto something or is this just another dead ...

Last October, we learned of BMW’s bids to secure trademark rights to the name “CSL,” which it originally made famous through its 3.0 CSL, built as a homologation requirement for the company to field ...

(Reuters) -Australian biotech CSL, the country's fourth-largest company, said on Tuesday it would spin off its vaccine division and shed about 3,000 employees as it reels from "unprecedented ...

MELBOURNE, Aug. 18, 2025 /PRNewswire/ -- Global biotherapeutics leader CSL today announced a reported net profit after tax of US$3.0 billion for the 12 months ended 30 June 2025, up 17% on a constant ...